Scribe Therapeutics

SCTX · NASDAQ

$19.81+$0.42 (+2.17%)TodayMarket closed ·
Prev close $19.39

Who owns SCTX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 64.7% of SCTX’s shares.

  • Avoro Capital Advisors LLC17.6%
  • Andreessen Horowitz15.6%
  • RA Capital Management, LP10.3%
  • OrbiMed Advisors, LLC7.7%
  • Next 6 largest institutions13.5%
  • All other shareholders35.3%
Top institutional holders of SCTX
HolderShares% of shares
Avoro Capital Advisors LLC3.09M17.57%
Andreessen Horowitz2.75M15.64%
RA Capital Management, LP1.80M10.25%
OrbiMed Advisors, LLC1.35M7.67%
Doudna (Jennifer A)616.06K3.50%
Staahl (Brett)524.34K2.98%
Oakes (Benjamin L. Ph.D.)506.60K2.88%
ARK Investment Management LLC352.10K2.00%
Gordon (Carl L)348.82K1.98%
Lucas (Svetlana)30.70K0.17%

Largest mutual fund holders

Top mutual fund holders of SCTX
HolderShares% of shares
ARK Genomic Revolution ETF411.34K2.34%
Franklin Templeton Investment Funds -Biotechnology Discovery244.43K1.39%
Vanguard Total Stock Market Index Fund15.46K0.09%
EQ/T Rowe Price Health Sciences Portfolio6.51K0.04%
Vanguard Extended Market Index Fund5.75K0.03%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $71.34M (9 trades) of SCTX on the open market, with no sales.

Latest SCTX insider transactions
InsiderTypeSharesValue
Aghazadeh BehzadBuy7.91K$144.27K
ORBIMED ADVISORS LLCOther2.07M—
ORBIMED ADVISORS LLCBuy1.00M$15.00M
ORBIMED ADVISORS LLCOther348.82K—
Doudna Jennifer AOther74.09K—
Doudna Jennifer AOther12.51K—
GORDON CARL LOther2.07M—
GORDON CARL LBuy1.00M$15.00M
GORDON CARL LOther348.82K—
AH Bio Fund II, L.P.Other4.13M—

Short interest

Settled Sep 30, 2026

Shares short
2.47M
Days to cover
3.58
% of shares outstanding
14.03%
Average daily volume
689.64K
Change since last report
+212.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.